Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00770887 · ClinicalTrials.gov registry record
Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 50
- Enrollment target
NCT00770887: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT00770887 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00770887 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to assess continuation rates and patient satisfaction with self administration subcutaneous depot medroxyprogesterone acetate.
Interventions
- PROCEDURE Self administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-06 |
What the finished NCT00770887 record still lists
NCT00770887 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Self administration is the first listed.
NCT00770887 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00770887 about?
NCT00770887 is a clinical study titled "Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate". The purpose of this study is to assess continuation rates and patient satisfaction with self administration subcutaneous depot medroxyprogesterone acetate.
What is the current status of trial NCT00770887?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2010-05. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00770887?
The interventions under investigation include: Self administration (PROCEDURE).
Who is sponsoring clinical trial NCT00770887?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia